AB
THRD

Amalgamated Bank’s Third Harmonic Bio THRD Stock Holding History

Amalgamated Bank’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-665
Closed -$4K – 3003
2025
Q3 		$4K Hold
665
– – ﹤0.01% 2869
2025
Q2 		$4K Hold
665
– – ﹤0.01% 2884
2025
Q1 		$2K Hold
665
– – ﹤0.01% 2875
2024
Q4 		$7K Hold
665
– – ﹤0.01% 2624
2024
Q3 		$9K Hold
665
– – ﹤0.01% 2523
2024
Q2 		$9K Hold
665
– – ﹤0.01% 2531
2024
Q1 		$6K Sell
665
-1,737
-72% -$16.9K ﹤0.01% 2681
2023
Q4 		$26K Buy
2,402
+365
+18% +$2.89K ﹤0.01% 2542
2023
Q3 		$13K Buy
2,037
+1,313
+181% +$8.03K ﹤0.01% 2848
2023
Q2 		$3K Sell
724
-640
-47% -$3.05K ﹤0.01% 3014
2023
Q1 		$6K Sell
1,364
-117
-8% -$497 ﹤0.01% 2883
2022
Q4 		$6K Buy
+1,481
New +$24.8K ﹤0.01% 2926

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Amalgamated Bank's THRD Position: Q4 2025 in Review

Amalgamated Bank sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 665 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in THRD in Q4 2022 and held it in 12 quarters. The position peaked at $26K in Q4 2023. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Amalgamated Bank reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Amalgamated Bank sold 665 Third Harmonic Bio shares in Q4 2025, an estimated $4K.
  • Amalgamated Bank first reported a position in Third Harmonic Bio in Q4 2022 and held it in 12 quarters.
  • Amalgamated Bank's Third Harmonic Bio position peaked at $26K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Amalgamated Bank's 13F filing for Q4 2025, filed 5 Feb 2026.